TechRadar News.
Business

Former OpenAI Research Lead Raises $215 Million to Automate Wet‑Lab Work with Robots

Former OpenAI Research Lead Raises $215 Million to Automate Wet‑Lab Work with Robots

A biotech venture called Warp Science disclosed its launch this week, revealing a $215 million funding round headed by the venture firm Lightspeed. The money will fund the creation of robotic platforms capable of handling everyday lab tasks such as pipetting and sample manipulation, with the goal of converting conventional wet‑lab operations into a mostly automated workflow.

The startup’s founder previously led the science division at OpenAI, directing research that merged artificial intelligence with hands‑on experimentation. After departing the AI company, he turned his focus to the persistent bottlenecks in biological research, pointing out that many experiments remain labor‑intensive despite progress in computational tools.

Warp Science intends to combine modular robotic arms, vision‑based quality checks, and software that can convert experimental protocols into machine‑readable commands. By taking over repetitive duties, the system aims to free researchers for higher‑level analysis and speed up discovery, especially in drug development and synthetic biology where throughput and reproducibility are essential.

The $215 million injection places Warp Science alongside a growing group of firms modernizing lab infrastructure. Venture capital has increasingly poured into automation, with companies like Benchling, LabTwin and others drawing sizable investments lately. Observers interpret the sizable round as a vote of confidence in the commercial promise of fully robotic wet‑lab workflows, a field that has traditionally trailed data‑centric AI uses.

Although the technology remains in prototype form, Warp Science plans to roll out its first commercial system within the next 12 to 18 months, aiming at large research institutions and pharmaceutical R&D labs. The company will have to address regulatory issues tied to laboratory equipment and prove consistent reliability before wider uptake. Success could transform experimental biology, ushering in a period where robots manage routine work while scientists concentrate on hypothesis generation and interpretation.

Source: techcrunch
TechRadar Desk — Editorial desk.

Comments (0)

Be the first to comment.

Join the discussion

Protected by reCAPTCHA v3

Related